RedixFi
Pre-openNIFTY24,536.6+2.4%
Market feed live

SHIVATEX · Shiva Texyarn Ltd · Apparel/Accessories

SHIVATEX · Shiva Texyarn Ltd · Apparel/Accessories

₹166.13+0.2%

As of 05 Nov close

52-week range

52wk low ₹126.0652wk high ₹217.92

23.8% below 52-week high

52-week range: as of 05 Nov 2026 close.

Price chartDaily closes on the stock page.

Stock Condition:Pro

Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.

Full signal detail →

Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old

Profit declined YoY for 2 straight quarters

Revenue (latest Q)

₹74 Cr

Revenue YoY

PAT YoY

-24.4%

Operating margin

Revenue, last 8 quarters

P/E (TTM)

P/B

1.6

P/S (TTM)

0.7

Sector P/E

Not available from data source

Dividend yield

+0.3%

CompanyP/EP/BNet marginROED/EDiv. yield
SHIVATEX (this stock)20.71.6+2.7%+6.3%0.51+0.3%
Page Industries61.125.7+14.1%+50.3%0.18+1.7%
Vardhman Textiles21.41.5+8.3%+8.1%0.18+0.9%
Pearl Global Industries34.76.6+5.4%+21.2%23.18+0.8%

Promoter

stable

FII

rising 1q

MF

Not available from data source

Insider trades

DateInsiderTypeQtyValue
09 Sept 2026VEDANAYAGAM HOSPITAL PRIVATE LIMITEDSELL1,50,000₹2.39 Cr
09 Sept 2026VEDANAYAGAM HOSPITAL PRIVATE LIMITEDSELL1,50,000₹1
09 Sept 2026S K SUNDARARAMANBUY1,50,000₹2.39 Cr

Bulk/block deals

No bulk/block deals in the last 12 months.

News timeline

No related news.

Concalls & investor presentations

AI-generated

No concall transcripts or investor presentations recorded yet.

AI Summary of Annual Report

AI-generated
FY2025-26173 pages

Shiva Texyarn Limited (SHIVATEX) for FY2025-26 reports no significant audit issues, defaults, or regulatory actions. The company amended its Memorandum of Association (MOA) to expand operational areas and seeks member approval for a special resolution. The Board recommends ratifying the remuneration of the Cost Auditor for FY2027. Internal controls are deemed adequate, with no material frauds reported. The company faces industry-specific risks like fluctuating raw material costs and potential impacts from geopolitical events, but maintains a positive outlook due to government support for the textile sector. Financial performance shows a decline in net profit margin and return on net worth compared to the previous year, with key financial ratios indicating reduced short-term borrowings and improved liquidity.

  • Amended MOA to expand operational areas, requiring member approval for a special resolution.
  • Ratification of Cost Auditor's remuneration for FY2027 is sought from members.
  • No material frauds reported, and internal controls are considered adequate.
  • Industry risks include fluctuating raw material costs and geopolitical impacts, but government initiatives support the textile sector.
  • Financial performance shows a decline in net profit margin and return on net worth compared to the previous year.

Key takeaway: Shiva Texyarn Limited has no major audit or regulatory issues, but faces industry-specific risks. Financial performance shows a decline in profitability, though government support and internal controls are viewed positively.

The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.

Filed with NSE · 30 Jul 2026View source filing →

Governance disclosures

AI-generated

Needs attention

No item of a kind that needs attention was stored for this company.

Contingent Liability

2 occurrences

Earlier (1-3 years ago)

Annual Report24 Jul 2025 (FY2024-25)· 2 passages
View source filing →

The company has disclosed the impact of pending litigations as on March 31, 2025 on its financial position in its Financial Statements – Refer Note 41 on Contingent Liabilities to the Financial Statements.

Annual Report25 Jul 2024 (FY2023-24)· 3 passages
View source filing →

The company has disclosed the impact of pending litigations as on March 31, 2024 on its financial position in its Standalone Financial Statements – Refer Note no 41 on Contingent Liabilities.

Related-Party Transaction

1 occurrence

Earlier (1-3 years ago)

Annual Report25 Jul 2024 (FY2023-24)
View source filing →

The company has related party transactions with entities such as Vedanayagam Hospital Private Limited, Anamallais Agencies Private Limited, and others, where these parties have significant influence on the company or are influenced by key managerial personnel or their relatives.

Open full Signal Dashboard →